BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2889527)

  • 1. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system.
    Reubi JC; Lang W; Maurer R; Koper JW; Lamberts SW
    Cancer Res; 1987 Nov; 47(21):5758-64. PubMed ID: 2889527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptors in human endocrine tumors.
    Reubi JC; Maurer R; von Werder K; Torhorst J; Klijn JG; Lamberts SW
    Cancer Res; 1987 Jan; 47(2):551-8. PubMed ID: 3024822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.
    Reubi JC; Chayvialle JA; Franc B; Cohen R; Calmettes C; Modigliani E
    Lab Invest; 1991 Apr; 64(4):567-73. PubMed ID: 1673164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cell proliferation and glial fibrillary acidic protein in brain tumors].
    Kunz J; Gottschalk J; Jänisch W; Schulz W
    Acta Histochem; 1986; 80(1):53-61. PubMed ID: 3099535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification.
    Reubi JC; Waser B; Laissue JA; Gebbers JO
    Cancer Res; 1996 Apr; 56(8):1922-31. PubMed ID: 8620515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptors in differentiated ovarian tumors.
    Reubi JC; Horisberger U; Klijn JG; Foekens JA
    Am J Pathol; 1991 May; 138(5):1267-72. PubMed ID: 1850962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors.
    Reubi JC; Horisberger U; Lang W; Koper JW; Braakman R; Lamberts SW
    Am J Pathol; 1989 Feb; 134(2):337-44. PubMed ID: 2537015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Steroid receptors in the central nervous system. Implications in neurology].
    Poisson M; Pertuiset BF; Moguilewsky M; Magdelenat H; Martin PM
    Rev Neurol (Paris); 1984; 140(4):233-48. PubMed ID: 6371995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of evidence for autocrine feedback regulation by somatostatin in somatostatin receptor-containing meningiomas.
    Reubi JC; Mengod G; Palacios JM; Horisberger U; Hackeng WH; Lamberts SW
    Cell Growth Differ; 1990 Jun; 1(6):299-303. PubMed ID: 1980601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytologic diagnosis of glial tumors of the central nervous system].
    Shakunov AN; Triputin ES
    Arkh Patol; 1987; 49(1):41-6. PubMed ID: 3827633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glial fibrillary acidic protein and central nervous tumors. Immunohistochemical study of a series of 207 cases. 1: Astrocytomas. Glioblastomas. Ependymomas. Papillomas of the choroid plexus].
    Pasquier B; Lachard A; Pasquier D; Couderc P; Delpech B; Courel MN
    Ann Pathol; 1983; 3(2):127-35. PubMed ID: 6307324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
    Hasselblatt M; Paulus W
    Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
    Sasaki T; Lopes MB; Hankins GR; Helm GA
    Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A.
    Schulz S; Pauli SU; Schulz S; Händel M; Dietzmann K; Firsching R; Höllt V
    Clin Cancer Res; 2000 May; 6(5):1865-74. PubMed ID: 10815909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical study of c-myc oncogene product in human brain tumors].
    Nakajima Y; Yoshimine T; Hayakawa T; Maruno M; Mushiroi T; Nakagawa H; Mogami H
    No To Shinkei; 1989 Jun; 41(6):617-21. PubMed ID: 2679824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical localization of apolipoprotein E in human glial neoplasms.
    Murakami M; Ushio Y; Morino Y; Ohta T; Matsukado Y
    J Clin Invest; 1988 Jul; 82(1):177-88. PubMed ID: 3392206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas.
    Reubi JC; Waser B; Khosla S; Kvols L; Goellner JR; Krenning E; Lamberts S
    J Clin Endocrinol Metab; 1992 May; 74(5):1082-9. PubMed ID: 1349024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glial fibrillary acidic protein and central nervous system tumors. Immunohistochemical study of a series of 207 cases. 2: Medulloblastomas. Hemangioblastomas. Other tumors. Discussion].
    Pasquier B; Lachard A; Pasquier D; Couderc P; Delpech B; Courel MN
    Ann Pathol; 1983 Sep; 3(3):203-11. PubMed ID: 6354202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin receptor imaging with 123I-Tyr3-Octreotide.
    Lamberts SW; Reubi JC; Bakker WH; Krenning EP
    Z Gastroenterol; 1990 Sep; 28 Suppl 2():20-1. PubMed ID: 1980773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvessel density in brain tumors.
    Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
    Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.